Episurf Medical delivered record Q1 sales and order intake, improved cost control, and a reduced loss, driven by US and European expansion. Strategic partnerships and a growing customer base support the goal of doubling sales annually to reach cash flow positivity.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.